Investigating the protective role of retinal lipoxins in glaucoma
Homeostatic Role and Therapeutic Potential of the Neuroprotective Retinal Lipoxin Circuit
['FUNDING_R01'] · UNIVERSITY OF CALIFORNIA BERKELEY · NIH-10798194
This study is looking at how certain cells in the eye can create helpful substances that might protect against cell damage in glaucoma, which is a major cause of blindness, and it aims to find new ways to keep your vision safe.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA BERKELEY (nih funded) |
| Locations | 1 site (BERKELEY, UNITED STATES) |
| Trial ID | NIH-10798194 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding how retinal astrocytes produce neuroprotective lipoxins that may help prevent cell death in glaucoma, a leading cause of blindness. The project aims to explore the mechanisms by which these lipoxins function and their potential as therapeutic targets. By studying the interactions between astrocytes and retinal ganglion cells, the research seeks to uncover new strategies for neuroprotection in glaucoma patients. The approach includes biochemical assays and cellular models to evaluate the effects of lipoxins on cell survival and inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glaucoma or those at high risk for developing the condition.
Not a fit: Patients with other forms of vision impairment unrelated to glaucoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new neuroprotective therapies that prevent vision loss in glaucoma patients.
How similar studies have performed: Previous research has shown promise in using lipid mediators for neuroprotection in other contexts, suggesting potential success for this novel approach in glaucoma.
Where this research is happening
BERKELEY, UNITED STATES
- UNIVERSITY OF CALIFORNIA BERKELEY — BERKELEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GRONERT, KARSTEN — UNIVERSITY OF CALIFORNIA BERKELEY
- Study coordinator: GRONERT, KARSTEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.